Scarica l'app Stockscreener
4.40
2.00%
-0.09
Dopo l'orario di chiusura:
4.41
0.010
+0.23%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RCEL Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.49
Aprire:
$4.44
Volume 24 ore:
120.11K
Relative Volume:
0.41
Capitalizzazione di mercato:
$135.42M
Reddito:
$72.35M
Utile/perdita netta:
$-45.34M
Rapporto P/E:
-2.8017
EPS:
-1.5705
Flusso di cassa netto:
$-32.43M
1 W Prestazione:
-4.56%
1M Prestazione:
+6.54%
6M Prestazione:
-0.23%
1 anno Prestazione:
-16.98%
Intervallo 1D:
$4.2449
$4.57
Intervallo di 1 settimana:
$4.2449
$4.87
Portata 52W:
$3.22
$7.12
Avita Medical Inc Stock (RCEL) Company Profile
Nome
Avita Medical Inc
Settore
Industria
Telefono
661-568-1317
Indirizzo
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
4.40 | 146.19M | 72.35M | -45.34M | -32.43M | -1.5705 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-05 | Iniziato | Northland Capital | Outperform |
| 2025-11-20 | Aggiornamento | BTIG Research | Sell → Neutral |
| 2025-08-08 | Downgrade | BTIG Research | Neutral → Sell |
| 2024-12-24 | Iniziato | D. Boral Capital | Buy |
| 2024-04-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-06-27 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-03-02 | Iniziato | Piper Sandler | Overweight |
| 2020-08-27 | Iniziato | BofA Securities | Buy |
| 2020-04-21 | Iniziato | Oppenheimer | Outperform |
| 2020-03-03 | Iniziato | BTIG Research | Buy |
Mostra tutto
Avita Medical Inc Borsa (RCEL) Ultime notizie
RCEL|AVITA Medical Inc|Price:4.760|Chg%:+0.150 - TradingKey
AVITA Medical Inc (RCEL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AVITA Medical Inc (RCEL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
AVITA Medical Inc (RCEL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
AVITA Medical Inc (RCEL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AVITA Medical Inc (RCEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AVITA Medical Inc (RCEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
AVITA Medical Inc (RCEL) Cash Flow - TradingKey
RCEL|AVITA Medical Inc|Price:4.610| - TradingKey
Avita Medical Inc. (NASDAQ:RCEL) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Avita Medical (NASDAQ:RCEL) Downgraded to "Sell" Rating by Wall Street Zen - MarketBeat
AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs Revenue Breakdown – MUN:51KB - TradingView
AVITA Medical Inc (RCEL) Valuation: PE, PB & Fair Value Analysis - TradingKey
RCEL stock trades near recent highs as Avita Medical revenue accelerates - Ad-hoc-news.de
Avita Medical (ASX:AVH) Gains 4.00% as Commercial Expansion of Regenerative Medicine Platform Continues - Kalkine
Analysts Offer Insights on Healthcare Companies: Avita Medical (RCEL), Tenaya Therapeutics (TNYA) and Elevance Health (ELV) - The Globe and Mail
AVITA Medical to announce Q2 2026 financial results on August 6 - scanx.trade
AVITA Medical to Announce Second Quarter 2026 Financial Results - Investing News Network
AVITA Medical Schedules Q2 Results Call for Aug. 6 Webcast - Stock Titan
AVITA Medical (RCEL) Stock Sees Fair Value Lift As Analysts Back RECELL Momentum - Yahoo Finance
AVITA Medical (ASX:AVH) Shares Drop More Than 5%: What Investors May Be Watching Next - Kalkine
Enterprise value to EBITDA forward of AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs – MUN:51KB - TradingView
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Avita Medical (RCEL) Upgraded to Buy: Here's Why - Yahoo Finance
Avita Medical Options and Restricted Stock Units Lapse Across Multiple Security Classes - Kalkine
Avita Medical Downgraded to Hold From Speculative Buy by Morgans - Moomoo
Avita Medical Reports Expiry of Over 140,000 Unquoted Securities Across Multiple Series - Kalkine Media
Avita Medical Stock Price Forecast. Should You Buy RCEL? - StockInvest.us
ASX Medical Innovation Stocks Worth Watching in July 2026 - Kalkine
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Raises Target Price to $12 - Moomoo
Price to sales forward of AVITA Medical Inc Shs Chess Depository Interests repr 0.2 shs – ASX:AVH - TradingView
AVITA Medical, Inc.(NasdaqCM:RCEL) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2500 Growth Benchmark - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2000 Growth Benchmark - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2000 Dynamic Index - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 3000E Index - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2500 Index - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 3000 Index - marketscreener.com
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 2000 Index - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating AVITA Medical - The National Law Review
AVITA Medical, Inc.(NasdaqCM: RCEL) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Price to book forward of AVITA Medical Inc – LS:A2P733 - TradingView
Lake Street Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $6 - Moomoo
Price to sales forward of Avita Medical, Inc. – NASDAQ:RCEL - TradingView
Avita Medical (RCEL) Slips to Key Support as Downside Momentum PersistsNHNL Divergence - dars.gov.et
BTIG Maintains Avita Medical(RCEL.US) With Hold Rating - Moomoo
Avita Medical (RCEL) Slips 2.73%: Testing Key Support Near $3.72Weekly Profile - dars.gov.et
AVITA Medical (RCEL) Showcases RECELL GO Clinical Data at UK Con - GuruFocus
AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting - Investing News Network
AVITA Medical’s burn treatment used in 17 U.K. patients - Stock Titan
AVITA Medical Inc (RCEL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Avita Medical Inc Azioni (RCEL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Avita Medical Inc Azioni (RCEL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Woody Joseph Fralin | Director |
Jun 09 '26 |
Buy |
4.19 |
10,000 |
41,900 |
102,761 |
| Woody Joseph Fralin | Director |
Jun 03 '26 |
Buy |
4.09 |
10,000 |
40,949 |
92,761 |
| Woody Joseph Fralin | Director |
Jun 01 '26 |
Buy |
4.30 |
10,000 |
43,000 |
10,000 |
| Woody Joseph Fralin | Director |
Jun 02 '26 |
Buy |
4.19 |
10,000 |
41,936 |
20,000 |
| O'Toole David D | CFO |
May 20 '26 |
Buy |
4.26 |
2,000 |
8,520 |
145,927 |
| O'Toole David D | CFO |
May 19 '26 |
Buy |
4.24 |
2,000 |
8,480 |
143,927 |
| O'Toole David D | CFO |
Feb 19 '26 |
Buy |
4.15 |
3,000 |
12,450 |
140,127 |
| McNamara Robert | Director |
Aug 28 '25 |
Buy |
4.50 |
10,000 |
45,000 |
86,771 |
| O'Toole David D | CFO |
Aug 26 '25 |
Buy |
4.52 |
2,000 |
9,040 |
31,657 |
| McNamara Robert | Director |
Aug 19 '25 |
Buy |
5.00 |
10,000 |
50,000 |
76,771 |
1.04%
11.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):